| Literature DB >> 17760981 |
Carien H G Beurskens1, Caro J T van Uden, Luc J A Strobbe, Rob A B Oostendorp, Theo Wobbes.
Abstract
BACKGROUND: Many patients suffer from severe shoulder complaints after breast cancer surgery and axillary lymph node dissection. Physiotherapy has been clinically observed to improve treatment of these patients. However, it is not a standard treatment regime. The purpose of this study is to investigate the efficacy of physiotherapy treatment of shoulder function, pain and quality of life in patients who have undergone breast cancer surgery and axillary lymph node dissection.Entities:
Mesh:
Year: 2007 PMID: 17760981 PMCID: PMC2031897 DOI: 10.1186/1471-2407-7-166
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Patient characteristics of intervention group (n = 15) and control group (n = 15) at baseline, no significant differences present between both groups
| Intervention group (n = 15) | Control group (n = 15) | |
| n | n | |
| Age (mean, SD) | 53.7 (SD 13.0) | 55.4 (SD 9.3) |
| Affected side | ||
| | 6 | 7 |
| | 9 | 8 |
| Pre-existing shoulder complaints | ||
| | 13 | 12 |
| | 1 | 3 |
| | 1 | 0 |
| Surgery | ||
| | 3 | 4 |
| | 12 | 11 |
| Number of extirpated lymph nodes | ||
| | 2 | 2 |
| | 3 | 1 |
| | 10 | 12 |
| Post-surgery complications | ||
| | 8 | 9 |
| | 4 | 3 |
| | 1 | 3 |
| | 2 | 0 |
| Hospital | ||
| | 11 | 10 |
| | 4 | 5 |
Adjuvant therapy of intervention group (n = 15) and control group (n = 15)
| Intervention group (n = 15) | Control group (n = 15) | |
| n | n | |
| None | 3 | 0 |
| Radiation therapy (RT) | 0 | 2 |
| Chemotherapy | 2 | 2 |
| Hormonal therapy | 1 | 1 |
| Radiation therapy and chemotherapy | 6 | 8 |
| Chemotherapy and hormonal therapy | 1 | 1 |
| Radiation and hormonal therapy | 1 | 1 |
| Radio, chemo and hormonal therapy | 1 | 0 |
Mean and standard deviation of outcome variables at T0 (baseline), at T1 (after three months), and at T2 (six months)
| (n = 15) | (n = 15) | ( | ||||
| Outcome | ||||||
| Functional shoulder impairments (1–5) | 3.7 (0.6) | 1.7 (0.5) | 1.4 (0.8) | 2.9 (0.6) | 3.1 (0.7) | 2.4 (0.6) |
| VAS for pain (0–10) | 4.7 (1.6) | 1.3 (1.2) | 0.9 (1.1) | 4.2 (1.8) | 3.7 (1.6) | 3.2 (1.8) |
| Handgrip strength (Kg) | 26.0 (7.1) | 30.0 (6.3) | 30.0 (7.0) | 24.7 (10.5) | 25.7 (11.1) | 26.7 (10.1) |
| Anteflexion shoulder (0–180°) | 121 (23.5) | 166 (10.1) | 171 (13.5) | 133 (24.1) | 144 (27.0) | 153 (22.7) |
| Abduction shoulder (0–180°) | 96.5 (24.0) | 167 (15.2) | 170 (13.5) | 122 (28.9) | 135 (38.8) | 144 (34.3) |
| DASH (0–100) | 48.6 (18.6) | 18.7 (12.7) | 14.6 (10.7) | 40.5 (20.3) | 28.7 (19.1) | 21.6 (12.5) |
| SIP (0–68) | 9.1 (6.8) | 5.0 (4.5) | 4.4 (4.7) | 10.5 (9.1) | 10.1 (10.8) | 8.0 (8.3) |
| Volume operated arm (ml) | 255 (49.1) | 261 (55.9) | 268 (54.1) | 259 (42.9) | 263 (50.5) | 272 (48.5) |
VAS, Visual Analogue Scale; DASH, Disabilities of the Arm, Shoulder and Hand; SIP, Sickness Impact Profile.
Effect sizes of intervention group compared to control group on determined variables
| Value (95% CI) | Sign ( | Value (95% CI) | Sign ( | |
| Functional impairments (1 – 5) | -1.8 (-2.3 – -1.3) | <0.001 | -0.8 (-1.5 – -0.2) | 0.018 |
| VAS for pain (0–10) | -2.7 (-3.6 – -1.9) | <0.001 | -2.5 (-3.5 – -1.6) | <0.001 |
| Hand grip strength (Kg) | 3.1 (-0.4 – 6.6) | 0.081 | 1.4 (-2.4 – 5.2) | 0.452 |
| Anteflexion shoulder (0–180°) | 24.9 (9.3 – 40.5) | 0.003 | 19.3 (5.7 – 32.8) | 0.007 |
| Abduction shoulder (0–180°) | 36.7 (12.2 – 61.2) | 0.005 | 29.7 (7.9 – 51.5) | 0.010 |
| DASH (0–100) | -13.5 (-24.3 – -2.6) | 0.017 | -9.0 (-17.2 – -0.8) | 0.032 |
| SIP (0–68) | -4.0 (-7.7 – -0.3) | 0.035 | -2.8 (-6.7 – 1.0) | 0.142 |
| Volume operated arm (ml) | 1.6 (-20.2 – 23.5) | 0.880 | -0.6 (-20.7 – 19.4) | 0.950 |
a Effect sizes are calculated as differences between groups at T1 or T2 adjusted for the T0 assessment (entered as covariate in the analysis).
VAS, Visual Analogue Scale; DASH, Disabilities of the Arm, Shoulder and Hand; SIP, Sickness Impact Profile.